Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

Cited by (1,002)

Items 801–900 of 1,002

  1. Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer
    Narjess Bostanghadiri, Shabnam Razavi, Aref Shariati, Malihe Talebi, Shiva Mirkalantari, Àmirnader Emami Razavi, Davood Darban‐Sarokhalil · 2023 · Frontiers in Microbiology
  2. Fabrication of hyaluronic acid-inulin coated Enterococcus faecium for colon-targeted delivery to fight Fusobacterium nucleatum
    Pengrong Zhu, Lingtong Meng, Yue Shu, Yuqiao Xu, Weiming Liu, Yong Bi, Jian Xu, Lijuan Meng, Yanan Li · 2024 · Carbohydrate Polymers
  3. The dual role of autophagy in the regulation of cancer treatment
    Louis Boafo Kwantwi · 2024 · Amino Acids
  4. Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
    Tanushree Mondal, Deepanjan Chattopadhyay, Paromita Saha Mondal, Sanjib Das, Amalesh Mondal, Abhishek Das, Subhasree Samanta, Tanima Saha · 2025 · International Journal of Biological Macromolecules
  5. Overexpression of Toll-Like Receptor 4 Affects Autophagy, Oxidative Stress, and Inflammatory Responses in Monocytes of Transgenic Sheep
    Sutian Wang, Xu-Ting Song, Kunli Zhang, Shoulong Deng, Peixin Jiao, Mei-Yu Qi, Zhengxing Lian, Yuchang Yao · 2020 · Frontiers in Cell and Developmental Biology
  6. Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p Axis
    Ze Yu, Yuezhen Wang, Bin Wang, Junwei Zhai · 2020 · Cancer Biotherapy and Radiopharmaceuticals
  7. Comparison of clinicopathological parameters, prognosis, micro-ecological environment and metabolic function of Gastric Cancer with or without Fusobacterium sp. Infection
    Siru Nie, Ang Wang, Yuan Yuan · 2020 · Journal of Cancer
  8. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine
    Li Wang, Fu Peng, Cheng Yun Peng, Junrong Du · 2021 · The American Journal of Chinese Medicine
  9. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
    Emanuele Rinninella, Pauline Celine Raoul, Marco Cintoni, Marta Palombaro, Gabriele Pulcini, Antonio Gasbarrini, Maria Cristina Mele · 2021 · Microorganisms
  10. Gut Microbiota: A Potential Target for Cancer Interventions
    Hu Zhou, Yuan Yuan, Haorun Wang, Wei Xiang, Shenjie Li, Haowen Zheng, Yuqi Wen, Ming Yang, Ligang Chen, Jie Zhou · 2021 · Cancer Management and Research
  11. Evaluating the presence of Mycoplasma hyorhinis, Fusobacterium nucleatum, and Helicobacter pylori in biopsies of patients with gastric cancer
    Camila do Nascimento Araujo, Aline Teixeira Amorim, Maysa Santos Barbosa, Julieta Canjimba Porto Lucas Alexandre, Guilherme Barreto Campos, Cláudia Leal Macêdo, Lucas Miranda Marques, Jorge Timenetsky · 2021 · Infectious Agents and Cancer
  12. Microbial and molecular differences according to the location of head and neck cancers
    Yun Kyeong Kim, Eun Jung Kwon, Yeuni Yu, Jayoung Kim, Soo-Yeon Woo, Hee-Sun Choi, Munju Kwon, Keehoon Jung, Hyung-Sik Kim, Hae Ryoun Park et al. · 2022 · Cancer Cell International
  13. The role of gut microbiota in the development of colorectal cancer: a review
    Navami Prabhakar Koyande, Madhusree Gangopadhyay, Shashidhar Thatikonda, Aravind Kumar Rengan · 2022 · International Journal of Colorectal Disease
  14. Multi-Omics Integration Reveals the Crucial Role of Fusobacterium in the Inflammatory Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
    Han Qiao, Hui Li, Xian-Hui Wen, Xi-Rong Tan, Chongzhe Yang, Na Liu · 2022 · Microbiology Spectrum
  15. Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review
    Matu Li, Ya Zheng, Jinyu Zhao, Meimei Liu, Xiaochuang Shu, Qiang Li, Yuping Wang, Yongning Zhou · 2022 · Current Oncology
  16. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
    Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen et al. · 2022 · Frontiers in Immunology
  17. Isolation and characterization of novel Fusobacterium nucleatum bacteriophages
    Yue Wang, Zhitong Liu, Qian Chen, Liqi Yi, Zihao Xu, Mufeng Cai, Jinhong Qin, Yan Zhang, Guanhuan Du, Jie Hong et al. · 2022 · Frontiers in Microbiology
  18. Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
    Bo Liu, Yige Li, Lijun Suo, Wei Zhang, Hongyun Cao, Ruicai Wang, Jiahui Luan, Yu Xiaofeng, Liang Dong, Wenjing Wang et al. · 2022 · Frontiers in Oncology
  19. Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production
    Ning Ding, Yikun Cheng, Huijuan Liu, Yueguang Wu, Yongjia Weng, Heyang Cui, Cheng Chen, Weimin Zhang, Yongping Cui · 2023 · Microbiology Spectrum
  20. Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer
    Tingting Li, Liang Han, Simin Ma, Weiji Lin, Xin Wu Ba, Jiahui Yan, Ying Huang, Shenghao Tu, Kai Qin · 2023 · Frontiers in Molecular Biosciences
  21. Molecular principles of tissue invasion and metastasis
    Suresh Sulekha Dhanisha, Chandrasekharan Guruvayoorappan · 2023 · American Journal of Physiology-Cell Physiology
  22. Awareness of intratumoral bacteria and their potential application in cancer treatment
    Yin Liang, Qiyan Li, Yulin Liu, Yajie Guo, Qingjiao Li · 2023 · Discover Oncology
  23. Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review
    Roxana Loriana Negruț, Adrian Coțe, Adrian Marius Maghiar · 2023 · Microorganisms
  24. Effects of lactic acid bacteria isolated from Tibetan chickens on the growth performance and gut microbiota of broiler
    Lei Wang, Zhengrong Lin, Mahboob Ali, Xiaohui Zhu, Yu Zhang, Siyuan Li, Kun Li, Fareeda Kebzai, Jiakui Li · 2023 · Frontiers in Microbiology
  25. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
    Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara, Natalie Leys, Samir Kumar‐Singh, Surbhi Malhotra‐Kumar, Rob Van Houdt · 2023 · Frontiers in Cellular and Infection Microbiology
  26. Fusobacterium nucleatum carcinogenesis and drug delivery interventions
    Chen, Zhenzhen, Huang, Leaf · 2024 · Advanced Drug Delivery Reviews
  27. Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer
    Mingli Han, Hongbo Qu, Hui Cao, Xiangke Li, Dongwei Dou, Xue Yang, Yunqing Yang, Na Han, Mulin Ye, Jing Han et al. · 2020 · Retracted
  28. Enhanced Fusobacterium nucleatum Genetics Using Host DNA Methyltransferases To Bypass Restriction-Modification Systems
    Ariana Umaña, Tam T. D. Nguyen, Blake E. Sanders, Kevin J. Williams, Bryce Wozniak, Daniel Joseph Slade · 2022 · Journal of Bacteriology
  29. Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula
    Yun Qian, Zi‐Ran Kang, Licong Zhao, Huimin Chen, Cheng‐Bei Zhou, Qinyan Gao, Zheng Wang, Qiang Liu, Yun Cui, Xiaobo Li et al. · 2023 · Chinese Medical Journal
  30. Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases
    Eman K. E. Anwer, Muhammad Ajagbe, Mohamed A. Sherif, Abobaker Salem Musaibah, Shuaib Mahmoud, Ali ElBanbi, Anwar Abdelnaser · 2025 · Biomedicines
  31. Multifunctional nanodrug for simultaneously combating chemoresistance and immunosuppression in Fusobacterium nucleatum-associated colorectal cancer
    Xiaohui Li, Mengdi Wu, Yu Cheng Wu, Youtao Xin, Linran Gao, Mahmoud Elsabahy, Xuan Wang, Jimin Zhang, Xiongwei Qu, Hui Gao · 2025 · Acta Biomaterialia
  32. Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction
    S. Michelle Todd, Robert E. Settlage, Kevin K. Lahmers, Daniel Joseph Slade · 2018 · mSphere
  33. Nanotechnologies for enhancing cancer immunotherapy
    Jingxian Yang, Chunhui Wang, Shuo Shi, Chunyan Dong · 2020 · Nano Research
  34. The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
    Jae-Ho Kim, Heung Kyu Lee · 2021 · Molecules and Cells
  35. Cancer and immunotherapy: a role for microbiota composition
    Fiona Pham, Fabien Moinard‐Butot, Clélia Coutzac, Nathalie Chaput · 2021 · European Journal of Cancer
  36. ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
    Xiaonan Qiu, Lin Zheng, Xiuting Liu, Dan Hong, Mintong He, Zengqi Tang, Cuicui Tian, Guozhen Tan, Samuel T. Hwang, Zhenrui Shi et al. · 2021 · Frontiers in Immunology
  37. Biofunctional magnesium-coated Ti6Al4V scaffolds promote autophagy-dependent apoptosis in osteosarcoma by activating the AMPK/mTOR/ULK1 signaling pathway
    Xinghui Wei, Zhi Tang, Hao Wu, X. Zuo, Hui Dong, L. Tan, Wenchen Wang, Yingzhe Liu, Zhigang Wu, L. Shi et al. · 2021 · Materials Today Bio
  38. The Tissue-Associated Microbiota in Colorectal Cancer: A Systematic Review
    Carolina Pinto da Costa, Patrícia F Vieira, Melissa Mendes-Rocha, Joana Pereira‐Marques, Rui M. Ferreira, Céu Figueiredo · 2022 · Cancers
  39. Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review
    Zhixing He, Wei Tian, Qichun Wei, Jing Xu · 2022 · Frontiers in Immunology
  40. The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
    Xiaoli Feng, Zhenhao Li, Weihong Guo, Yanfeng Hu · 2023 · Frontiers in Immunology
  41. Intestinal organoids: A versatile platform for modeling gastrointestinal diseases and monitoring epigenetic alterations
    Mahsa Ghorbaninejad, Hamid Asadzadeh‐Aghdaei, Hossein Baharvand, Anna Meyfour · 2023 · Life Sciences
  42. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
    Nassiba Taib, Maysaloun Merhi, Varghese Philipose Inchakalody, Sarra Mestiri, Shereena Hydrose, Karama Makni‐Maalej, Afsheen Raza, Fairooz Sahir, Fouad Azizi, Parveen Banu Nizamuddin et al. · 2023 · Journal of Translational Medicine
  43. Bile Acids and Microbiota Interplay in Pancreatic Cancer
    Pratibha Malhotra, Ranjith Palanisamy, Jose Antonio Caparros-Martin, Marco Falasca · 2023 · Cancers
  44. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
    Russell Gardner Witt, Samuel H. Cass, Tiffaney Tran, Ashish V. Damania, Emelie E Nelson, Elizabeth Sirmans, Elizabeth M. Burton, Manoj Chelvanambi, Sarah B. Johnson, Hussein A. Tawbi et al. · 2023 · JAMA Dermatology
  45. A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome
    Garreth W. Lawrence, Enriqueta García-Gutiérrez, A. Kate O’Mahony, Calum J. Walsh, Paula M. O’Connor, Máire Begley, Caitriona M. Guinane, Paul D. Cotter · 2024 · mBio
  46. Peritoneal Metastases in Colorectal Cancer
    Richard A. Jacobson, Scott K. Sherman, Fadi Dadaleh, Kiran Kalyan Turaga · 2018 · Annals of Surgical Oncology
  47. Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds
    Chiara Pierantoni, Lorenzo Cosentino, Luigi Ricciardiello · 2024 · Digestive Diseases
  48. Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers
    Elahe Akbari, Joel Brian Epstein, Firoozeh Samim · 2024 · Current Oncology Reports
  49. Gastrointestinal Microbiota in Gastric Cancer: Potential Mechanisms and Clinical Applications—A Literature Review
    Mengjiao Wu, Chenjun Tian, Zhenwei Zou, Jin Min, Hongli Liu · 2024 · Cancers
  50. An interplay between human genetics and intratumoral microbiota in the progression of colorectal cancer
    Jing Yu, Yuxuan Liang, Qingrong Zhang, Hui Ding, Minghao Xie, Jingjing Zhang, Wenyan Hu, Shuguang Xu, Yiyuan Xiao, Sha Xu et al. · 2025 · Cell Host & Microbe
  51. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa
    Garreth W. Lawrence, Máire Begley, Paul D. Cotter, Caitriona M. Guinane · 2020 · International Journal of Molecular Sciences
  52. Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
    Simone Anfossi, George A. Călin · 2020 · Cancer Drug Resistance
  53. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy
    Juan Tan, Hao-Lian Wang, Jie Yang, Qianqian Liu, Chunmin Li, Yun-Qian Wang, Linna Fu, Qin‐Yan Gao, Yingxuan Chen, Jing‐Yuan Fang · 2020 · Theranostics
  54. Entamoeba gingivalis Exerts Severe Pathogenic Effects on the Oral Mucosa
    X. Bao, January Mikolaj Weiner, O. Meckes, Henrik Dommisch, Arne S. Schäefer · 2021 · Journal of Dental Research
  55. The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study
    Mengyu Rui, Xinyi Zhang, Jinyun Huang, Dongliang Wei, Zhi Li, Ziyang Shao, Houyu Ju, Guoxin Ren · 2021 · Radiotherapy and Oncology
  56. Emerging actionable targets to treat therapy-resistant colorectal cancers
    Emanuela Grassilli, Maria Grazia Cerrito · 2022 · Cancer Drug Resistance
  57. Lucidone inhibits autophagy and MDR1 via HMGB1 / RAGE / PI3K /Akt signaling pathway in pancreatic cancer cells
    Sheng‐Yi Chen, Yi‐Hao Hsu, Sheng‐Yang Wang, Ying‐Yin Chen, Cheng‐Jie Hong, Gow‐Chin Yen · 2022 · Phytotherapy Research
  58. The tumour-associated microbiome
    Christopher D. Johnston, Susan Bullman · 2022 · Nature Reviews Gastroenterology & Hepatology
  59. Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes
    Robert A. Holt · 2023 · Cell Host & Microbe
  60. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
    Xiang Lin, Xinyu Yang, Yu‐Shang Yang, Hangbin Zhang, Xuan Huang · 2023 · Frontiers in Oncology
  61. Gut microbiome: decision-makers in the microenvironment of colorectal cancer
    Jingrun Han, Biao Zhang, Yongnian Zhang, Tianyi Yin, Yuying Cui, Jinming Liu, Yanfei Yang, Huiyi Song, Dong Shang · 2023 · Frontiers in Cellular and Infection Microbiology
  62. Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis
    Huiquan Liu, Li Lü, Jun Zou, Ting Zhou, Bangyan Wang, Huihui Sun, Shiying Yu · 2019 · BMC Complementary and Alternative Medicine
  63. Time-Course Transcriptome Analysis of Gingiva-Derived Mesenchymal Stem Cells Reveals That Fusobacterium nucleatum Triggers Oncogene Expression in the Process of Cell Differentiation
    Wenyan Kang, Tianyong Sun, Di Tang, Jiannan Zhou, Qiang Feng · 2020 · Frontiers in Cell and Developmental Biology
  64. Could Periodontal Disease through Periopathogen Fusobacterium nucleatum Be an Aggravating Factor for Gastric Cancer?
    Petra Șurlin, Flavia Mirela Nicolae, Valeriu Şurlin, Ștefan Pătrașcu, Bogdan Silviu Ungureanu, Andreea Cristiana Didilescu, Dan Ionuț Gheonea · 2020 · Journal of Clinical Medicine
  65. THSG alleviates cerebral ischemia/reperfusion injury via the GluN2B–CaMKII–ERK1/2 pathway
    Tonghe Liu, Jiayi Shi, Dahua Wu, Dandan Li, Yuhong Wang, Jian Liu, Pan Meng, Lijuan Hu, Chaojun Fu, Zhigang Mei et al. · 2024 · Phytomedicine
  66. Cancer and the Microbiome of the Human Body
    Lourdes Herrera‐Quintana, Héctor Vázquez‐Lorente, María López-Garzón, Adrián Cortés‐Martín, Julio Plaza‐Díaz · 2024 · Nutrients
  67. The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
    Jiali Yao, Beifang Ning, Jin Ding · 2025 · Gut Microbes
  68. Neutrophil‐Mimicking Nanomedicine Eliminates Tumor Intracellular Bacteria and Enhances Chemotherapy on Liver Metastasis of Colorectal Cancer
    Yanan Niu, Xu Zhao, Yong Li, Xiaoya Ma, Weifeng Yang, Jie Ma, Wanglin Li, Wei Yuan · 2025 · Advanced Science
  69. Oral microbiota–driven immune modulation along the oral–gut axis: from local signals to systemic inflammation
    Chunhao Principal Investigator Li, Yue Fan, Xingming Chen · 2026 · npj Biofilms and Microbiomes
  70. History and Current Status of Autophagy Research
    Rui Sheng, Zheng‐Hong Qin · 2019 · Advances in experimental medicine and biology
  71. Autophagy and Tumour Chemotherapy
    Xiaojuan Hou, Jinghua Jiang, Zhiqiang Tian, Lixin Wei · 2020 · Advances in experimental medicine and biology
  72. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy
    Indranil Chattopadhyay, Deeptashree Nandi, Alo Nag · 2020 · Seminars in Cancer Biology
  73. Drug–Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
    Ali A. Mohamed, Harry Menon, Marina Chulkina, Nelson S. Yee, Irina V. Pinchuk · 2021 · Biomedicines
  74. Microbiome in drug resistance to colon cancer
    Kavita Rajesh Pandey, Shahid Umar · 2021 · Current Opinion in Physiology
  75. The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer
    Zizhuo Wang, Rourou Xiao, Jia Ming Huang, Xu Qin, Dianxing Hu, Ensong Guo, Chen Liu, Funian Lu, Lixin You, Chaoyang Sun et al. · 2021 · Microbial Ecology
  76. Oral pathogen in the pathogenesis of colorectal cancer
    TaChung Yu, Yilu Zhou, Jing‐Yuan Fang · 2021 · Journal of Gastroenterology and Hepatology
  77. The microbiome, gastrointestinal cancer, and immunotherapy
    Rachel C. Newsome, Ye Yang, Christian Jobin · 2021 · Journal of Gastroenterology and Hepatology
  78. Microbe-based management for colorectal cancer
    Zi-Yun Gao, Zhe Cui, Yu-Qing Yan, Li-Jun Ning, Zhen-Hua Wang, Jie Hong · 2021 · Chinese Medical Journal
  79. Two-dimensional persistent luminescence “optical battery” for autophagy inhibition-augmented photodynamic tumor nanotherapy
    Meiqi Chang, Xinyue Dai, Caihong Dong, Hui Huang, Li Ding, Yu Chen, Wei Feng · 2021 · Nano Today
  80. Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status
    Sophie Shaw, Susan Berry, John Thomson, Graeme I. Murray, Emad M. El-Omar, Georgina Louise Hold · 2022 · Frontiers in Medicine
  81. Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics
    Xu Zhang, Krystal Walker, Janice Mayne, Leyuan Li, Zhibin Ning, Alain P. Stintzi, Daniel Figeys · 2022 · Gut Microbes
  82. Rapamycin Liposomes Combined with 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC (Min/+) Mice and AOM/DSS-Induced Colorectal Cancer Mice
    Xiaomin Liu, Wenting Zhu, Meng-Lei Jia, Yuting Li, Ye Hong, Zhongqiu Liu, Pengke Yan · 2022 · International Journal of Nanomedicine
  83. Huangqin Qingre Qubi Capsule inhibits RA pathology by binding FZD8 and further inhibiting the activity of Wnt/β-catenin signaling pathway
    Wanwan Zhou, Yuting Wang, Yurong Huang, Jian Liu, Chenglong Cheng, Qiuyun Xue, Xiao Dan Wang, Jun Chang, Chenggui Miao · 2022 · Journal of Ethnopharmacology
  84. Intratumor microbiota: a novel tumor component
    Yanyu Gong, Xinqi Huang, Minhui Wang, Xiaoqiu Liang · 2023 · Journal of Cancer Research and Clinical Oncology
  85. The Pathogenicity of Fusobacterium nucleatum Modulated by Dietary Fibers—A Possible Missing Link between the Dietary Composition and the Risk of Colorectal Cancer
    Sadia Nawab, Qelger Bao, Linhua Ji, Qian Luo, Xiang Fu, Shuxuan Fan, Zixin Deng, Wei Ma · 2023 · Microorganisms
  86. Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment
    Xinyi Zhang, Mengya Zhang, Hengqing Cui, Tinglin Zhang, Lili Wu, Can Xu, Chuan Yin, Jie Gao · 2023 · Journal of Controlled Release
  87. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
    Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, Alessandro Allegra · 2020 · International Journal of Molecular Sciences
  88. Epigenetics and environmental health
    Min Zhang, Ting Hu, Tianyu Ma, Wei Huang, Yan Wang · 2024 · Frontiers of Medicine
  89. Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
    Kamil Moskal, Nimisha Khurana, Luisa Siegert, Ye‐Seul Lee, Hans C. Clevers, Eran Elinav, Jens Puschhof · 2024 · International Journal of Cancer
  90. Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling
    Lixuan Wang, Weibo Jiang, Manshi Yang, Quezhu Danzeng, Shiyu Liu, Mengying Cui · 2025 · Cell Communication and Signaling
  91. Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments
    Liza Eiman, Khadija Moazzam, Sumaira Anjum, Humera Kausar, Elham Abdullatif M. Sharif, Wisam Nabeel Ibrahim · 2025 · Frontiers in Immunology
  92. The new microbiome on the block: challenges and opportunities of using human tumor sequencing data to study microbes
    Yingjie Li, Anjun Ma, William Evan Johnson, Charis Eng, Subhajyoti De, Sizun Jiang, Zihai Li, Daniel J. Spakowicz, Qin Ma · 2025 · Nature Methods
  93. Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment
    Zahra Sadeghloo, Amir Sadeghi · 2025 · Discover Oncology
  94. Ancient Thali Diet: Gut Microbiota, Immunity, and Health.
    Kaitlyn Shondelmyer, Rob D. Knight, Anusha Sanivarapu, Shuji Ogino, Jairam K. P. Vanamala · 2018 · Europe PMC (PubMed Central)
  95. Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide
    Jianbo Feng, Yan Zhang, Xing Ren, Di Li, Haijuan Fu, Changhong Liu, Wen Hu Zhou, Qing Liu, Qiang Liu, Minghua Wu · 2020 · Oncogene
  96. A Fragile Balance: The Important Role of the Intestinal Microbiota in the Prevention and Management of Colorectal Cancer
    Daniela Toumazi, Constantina Constantinou · 2020 · Oncology
  97. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
    Lili Duan, Wanli Yang, Weibo Feng, Lu Cao, Xiaoqian Wang, Liaoran Niu, Yiding Li, Wei Jie Zhou, Yujie Zhang, Jinqiang Liu et al. · 2020 · Therapeutic Advances in Medical Oncology
  98. The role of the oral microbiota in chronic non-communicable disease and its relevance to the Indigenous health gap in Australia
    Matilda Handsley‐Davis, Lisa Jamieson, Kostas Kapellas, Joanne Hedges, Laura Susan Weyrich · 2020 · BMC Oral Health
  99. Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota
    Sama Rezasoltani, Reza Ghanbari, Mehdi Azizmohammad Looha, Ehsan Nazemalhosseini Mojarad, Abbas Yadegar, Delisha A. Stewart, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali · 2020 · International Journal of Molecular Sciences
  100. Application of machine learning in prediction of Chemotherapy resistant of Ovarian Cancer based on Gut Microbiota
    Ting‐Ting Gong, Xinhui He, Song Gao, Qi‐Jun Wu · 2021 · Journal of Cancer